Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónUS20040176818 A1
Tipo de publicaciónSolicitud
Número de solicitudUS 10/731,869
Fecha de publicación9 Sep 2004
Fecha de presentación9 Dic 2003
Fecha de prioridad9 Dic 2002
También publicado comoDE60332272D1, DE60332764D1, DE60332871D1, EP1578493A1, EP1578494A1, EP1578494B1, EP1578495A1, EP1578495B1, EP1578496A1, EP1578497A1, EP1578497B1, EP1578498A1, EP1578499A1, EP1578500A1, US7212864, US7242982, US7392089, US7529586, US7848817, US8397732, US8457744, US8666497, US20040172090, US20040173221, US20040176673, US20040176814, US20040176815, US20040176816, US20040176817, US20040176819, US20070185539, US20110054563, WO2004052452A1, WO2004052452B1, WO2004052453A1, WO2004052453B1, WO2004052454A1, WO2004052454B1, WO2004052455A1, WO2004052455B1, WO2004052456A1, WO2004052456B1, WO2004052457A1, WO2004052457B1, WO2004052458A1, WO2004052458B1, WO2004052459A1, WO2004052459B1
Número de publicación10731869, 731869, US 2004/0176818 A1, US 2004/176818 A1, US 20040176818 A1, US 20040176818A1, US 2004176818 A1, US 2004176818A1, US-A1-20040176818, US-A1-2004176818, US2004/0176818A1, US2004/176818A1, US20040176818 A1, US20040176818A1, US2004176818 A1, US2004176818A1
InventoresCarl Wahlstrand, Ruchika Singhal, Robert Skime
Cesionario originalWahlstrand Carl D., Ruchika Singhal, Skime Robert M.
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos: USPTO, Cesión de USPTO, Espacenet
Modular implantable medical device
US 20040176818 A1
Resumen
An implantable medical device includes a plurality of separately housed and flexibly interconnected modules. A first module includes a control electronics within a first housing, and may be coupled to a second module that includes a second housing by a flexible interconnect member. In some embodiments, an overmold, which may be flexible, at least partially encapsulates the first and second housings. The second module may be a power source module that includes a power source, such as a rechargeable battery, within the second housing. The implantable medical device may also include a third module, such as a recharge module that includes a coil within a third housing. The overmold may at least partially encapsulate the third housing, or the third module may be tethered to the overmold by a flexible tether member. A flexible interconnect member and/or flexible overmold may allow multiples degrees of freedom of movement between modules of an implantable medical device.
Imágenes(14)
Previous page
Next page
Reclamaciones(57)
1. An implantable medical device comprising:
a first module that includes control electronics within a first housing;
a second module that includes a second housing; and
an overmold that at least partially encapsulates the first and second housings.
2. The implantable medical device of claim 1, wherein the second module includes a power source within the second housing that provides power to the first module.
3. The implantable medical device of claim 2, wherein the power source is rechargeable.
4. The implantable medical device of claim 3, further comprising a recharge coil that inductively receives energy to recharge the power source.
5. The implantable medical device of claim 4, wherein the recharge coil is located within the overmold and substantially encircles the first and second modules.
6. The implantable medical device of claim 4, further comprising a third module that includes a third housing that houses the recharge coil.
7. The implantable medical device of claim 6, wherein the overmold at least partially encapsulates the third module.
8. The implantable medical device of claim 7, wherein the first, second and third modules are positioned within the overmold in one of a triangular configuration and a linear configuration.
9. The implantable medical device of claim 6, wherein the third module is located outside of the overmold, the implantable medical device further comprising a flexible tether member that connects the third module to the overmold.
10. The implantable medical device of claim 9, wherein the flexible tether member comprises a helix.
11. The implantable medical device of claim 1, wherein the overmold completely encapsulates the first and second modules.
12. The implantable medical device of claim 1, wherein the overmold does not encapsulate a portion of each of the first and second modules, and each of the portions is proximate to a cranium of a patient when the implantable medical device is implanted on the cranium.
13. The implantable medical device of claim 1, wherein the overmold is flexible.
14. The implantable medical device of claim 1, wherein the overmold comprises silicone.
15. The implantable medical device of claim 1, wherein the overmold comprises at least two materials.
16. The implantable medical device of claim 1, further comprising a flexible interconnect member to couple the first and second modules.
17. The implantable medical device of claim 16, wherein the interconnect member is flexible in a plurality of directions and allows the first and second modules to have a plurality of degrees of freedom of movement relative to each other.
18. The implantable medical device of claim 1, wherein each of the first and second housings are substantially cylindrical.
19. The implantable medical device of claim 1, further comprising:
a lead connection module formed within the overmold to receive one of a lead that includes an electrode and a lead extension that is coupled to the lead; and
a conductor that extends from the lead connection module to the first module, wherein the first housing comprises a hermetic feedthrough to receive the conductor and the conductor electrically couples the electrode to the first module.
20. The implantable medical device of claim 1, wherein the first module comprises a therapy delivery circuit to deliver electrical stimulation to a patient, and the control electronics control the delivery of electrical stimulation by the therapy delivery circuit.
21. The implantable medical device of claim 1, wherein the overmold is shaped for implantation on a cranium of a patient.
22. The implantable medical device of claim 1, wherein the implantable medical device is flexible such that a shape of the implantable medical device is capable of being manipulated.
23. An implantable medical device comprising:
a first module that includes control electronics housed within a first housing;
a second module that includes a power source that provides power to the first module housed within a second housing; and
an interconnect member that flexibly couples the first and second modules.
24. The implantable medical device of claim 23, wherein the power source is rechargeable.
25. The implantable medical device of claim 24, further comprising a recharge coil that inductively receives energy to recharge the power source.
26. The implantable medical device of claim 25, wherein the recharge coil is located within an overmold and substantially encircles the first and second modules.
27. The implantable medical device of claim 25, further comprising a third module that includes a third housing that houses the recharge coil.
28. The implantable medical device of claim 27, wherein an overmold at least partially encapsulates the third module.
29. The implantable medical device of claim 28, wherein the first, second and third modules are positioned within the overmold in one of a triangular configuration and a linear configuration in which the modules are positioned substantially along a common axis.
30. The implantable medical device of claim 27, wherein the third module is located outside of the overmold, the implantable medical device further comprising a flexible tether member that connects the third module to the overmold.
31. The implantable medical device of claim 30, wherein the flexible tether member comprises a helix.
32. The implantable medical device of claim 23, wherein the interconnect member is flexible in a plurality of directions and allows the first and second modules to have a plurality of degrees of freedom of movement relative to each other.
33. The implantable medical device of claim 32, wherein the interconnect member allows the first and second modules to have at least three degrees of freedom of movement relative to each other.
34. The implantable medical device of claim 33, wherein the interconnect member is hermetic.
35. The implantable medical device of claim 23, wherein each of the first and second housings are substantially cylindrical.
36. The implantable medical device of claim 23, further comprising:
a lead connection module formed within an overmold to receive one of a lead that includes an electrode and a lead extension that is coupled to the lead; and
a conductor that extends from the lead connection module to the first module, wherein the first housing comprises a hermetic feedthrough to receive the conductor and the conductor electrically couples the electrode to the first module.
37. The implantable medical device of claim 23, wherein the first module comprises a therapy delivery circuit to deliver electrical stimulation to a patient, and the control electronics control the delivery of electrical stimulation by the therapy delivery circuit.
38. The implantable medical device of claim 23, wherein the implantable medical device is flexible such that a shape of the implantable medical device is capable of being manipulated.
39. An implantable medical device comprising:
a first module that includes control electronics housed within a first housing;
a second module that includes a power source that provides power to the first module housed within a second housing; and
a hermetic interconnect member that flexibly couples the first and second modules, wherein the interconnect member is flexible in a plurality of directions and allows the first and second modules to have a plurality of degrees of freedom of movement relative to each other.
40. The implantable medical device of claim 39, wherein the interconnect member allows the first and second modules to have at least three degrees of freedom of movement relative to each other.
41. The implantable medical device of claim 39, wherein the implantable medical device is flexible such that a shape of the implantable medical device is capable of being manipulated.
42. An implantable medical device comprising:
a first module comprising control electronics and a therapy delivery circuit housed within a first housing, wherein the control electronics control delivery of stimulation by the therapy delivery circuit;
a second module comprising a power source within a second housing that provides power to the control electronics and the therapy delivery circuit;
an interconnect member that flexibly couples the first and second modules and includes a conductor for delivery power from the power source to the control electronics and the therapy delivery circuit; and
a flexible overmold that at least partially encapsulates the first and second housings.
43. The implantable medical device of claim 42, wherein the power source is rechargeable.
44. The implantable medical device of claim 43, further comprising a recharge coil that inductively receives energy to recharge the power source.
45. The implantable medical device of claim 44, wherein the recharge coil is located within the flexible overmold and substantially encircles the first and second modules.
46. The implantable medical device of claim 44, further comprising a third module that includes a third housing that houses the recharge coil.
47. The implantable medical device of claim 46, wherein the flexible overmold at least partially encapsulates the third module.
48. The implantable medical device of claim 47, wherein the first, second and third modules are positioned within the overmold in one of a triangular configuration and a linear configuration in which the modules are positioned substantially along a common axis.
49. The implantable medical device of claim 46, wherein the third module is located outside of the overmold, the implantable medical device further comprising a flexible tether member that connects the third module to the overmold.
50. The implantable medical device of claim 49, wherein the flexible tether member comprises a helix.
51. The implantable medical device of claim 42, wherein the interconnect member is flexible in a plurality of directions and allows the first and second modules to have a plurality of degrees of freedom of movement relative to each other.
52. The implantable medical device of claim 42, further comprising:
a lead connection module formed within the overmold to receive one of a lead that includes an electrode and a lead extension that is coupled to the lead; and
a conductor that extends from the lead connection module to the first module, wherein the first housing comprises a hermetic feedthrough to receive the conductor and the conductor electrically couples the electrode to the first module.
53. The implantable medical device of claim 42, wherein the overmold is shaped for implantation on a cranium of a patient.
54. The implantable medical device of claim 42, wherein the implantable medical device is flexible such that a shape of the implantable medical device is capable of being manipulated.
55. The implantable medical device of claim 42, wherein the therapy delivery circuit comprises a pulse generator.
56. An implantable medical device comprising:
control electronics and a rechargeable power source that provides power for the control electronics within a first housing;
a recharge coil within a second housing that inductively receives energy to recharge the power source; and
a flexible tether member that connects the first and second housings.
57. The implantable medical device of claim 56, wherein the flexible tether member comprises a helix.
Descripción
  • [0001]
    This application claims the benefit of:
  • [0002]
    1. U.S. Provisional Application entitled “CRANIAL NEUROSTIMULATOR AND METHOD,” Serial No. 60/431,854, (Attorney Docket No. P-10891.00), filed on Dec. 9, 2002;
  • [0003]
    2. U.S. Provisional Application entitled “IMPLANTABLE CRANIAL MEDICAL DEVICES AND METHODS,” Serial No. 60/471,262, (Attorney Docket No. P-11462.00), filed on May 16, 2003;
  • [0004]
    3. U.S. Provisional Application entitled “IMPLANTABLE CRANIAL MEDICAL DEVICES AND METHODS,” Serial No. 60/503,945, (Attorney Docket No. P-11696.00), filed on Sep. 20, 2003;
  • [0005]
    4. U.S. Provisional Application entitled “IMPLANTABLE CRANIAL MEDICAL DEVICES AND METHODS,” Serial No. 60/503,946, (Attorney Docket No. P-11697.0), filed on Sep. 20, 2003; and
  • [0006]
    5. U.S. Provisional Application entitled “Thin Neuro Stimulation System, Device and Method,” Serial No. 60/507,857, (Attorney Docket No. P-20211.00), filed on Oct. 1, 2003.
  • [0007]
    The entire content of each of these U.S. Provisional Applications is incorporated herein by reference.
  • [0008]
    The following co-pending and commonly-assigned U.S. patent applications, filed on even date herewith, are also incorporated herein by reference in their entirety:
  • [0009]
    1. U.S. patent application entitled “CONCAVITY OF AN IMPLANTABLE MEDICAL DEVICE,” to Carl D. Wahlstrand et al., filed Dec. 9, 2003, assigned Attorney Docket No.: 1023-336US01/P-11800.00;
  • [0010]
    2. U.S. patent application entitled “IMPLANTATION OF LOW-PROFILE IMPLANTABLE MEDICAL DEVICE,” to Ruchika Singhal et al., filed Dec. 9, 2003, assigned Attorney Docket No.: 1023-330US01/P-11795.00;
  • [0011]
    3. U.S. patent application entitled “COUPLING MODULE OF A MODULAR IMPLANTABLE MEDICAL DEVICE,” to Darren A. Janzig et al., filed Dec. 9, 2003, assigned Attorney Docket No.: 1023-331US01/P-11796.00;
  • [0012]
    4. U.S. patent application entitled “OVERMOLD FOR A MODULAR IMPLANTABLE MEDICAL DEVICE,” to Ruchika Singhal et al., filed Dec. 9, 2003, assigned Attorney Docket No.: 1023-332US01/P-11798.00;
  • [0013]
    5. U.S. patent application entitled “REDUCING RELATIVE INTERMODULE MOTION IN A MODULAR IMPLANTABLE MEDICAL DEVICE,” to Carl D. Wahlstrand et al., filed Dec. 9, 2003, assigned Attorney Docket No.: 1023-333US01/P-11797.00;
  • [0014]
    6. U.S. patent application entitled “LEAD CONNECTION MODULE OF A MODULAR IMPLANTABLE MEDICAL DEVICE,” to Ruchika Singhal et al., filed Dec. 9, 2003, assigned Attorney Docket No.: 1023-334US01/P-11799.00;
  • [0015]
    7. U.S. patent application entitled “LOW-PROFILE IMPLANTABLE MEDICAL DEVICE,” to Darren A. Janzig et al., filed Dec. 9, 2003, assigned Attorney Docket No.: 1023-335US01/P-11801.00; and
  • [0016]
    8. U.S. patent application entitled “MODULAR IMPLANTABLE MEDICAL DEVICE,” to Carl D. Wahlstrand et al., filed Dec. 9, 2003, assigned Attorney Docket No.: P-20542.00.
  • TECHNICAL FIELD
  • [0017]
    The invention relates to medical devices, and more particularly, to implantable medical devices that deliver therapy to and/or monitor a patient.
  • BACKGROUND
  • [0018]
    Depending on the application for which they are implanted in a patient, implantable medical devices (IMDs) may include a variety of electrical and/or mechanical components. Typically, an IMD includes a rigid housing that houses all of its components, which are generally fragile, to protect the components from forces to which they would otherwise be exposed when implanted within the human body. In order to avoid potentially harmful interactions between the components and bodily fluids, e.g., corrosion, IMD housings are typically hermetically sealed. Many IMD housings are fabricated from Titanium because of its desirable rigidity and biocompatibility.
  • [0019]
    The size and shape of an IMD housing is dependant on the sizes and shapes of the components of the IMD. Large components common to most IMDs include a battery, a telemetry coil, and a circuit board that carries digital circuits, e.g., integrated circuit chips and/or a microprocessor, and analog circuit components. Attempts have been made to reduce the size of the IMD housing by reducing the size of these components, changing the shape of these components, and organizing these components within the IMD housing to avoid empty space within the housing. Despite these efforts to reduce the size of IMD housings, the size, shape and rigidity of IMD housings still greatly limits the locations within the human body where an IMD can be practically implanted.
  • [0020]
    Due to these limitations, an IMD is typically implanted within the abdomen, upper pectoral region, or subclavicular region of a patient. Leads or catheters must be used in order to deliver therapy or monitor a physiological parameter at a location of the body other than where the IMD is implanted. Implantation and positioning of leads and catheters can be difficult and time-consuming from the perspective of a surgeon, particularly where the IMD is located a significant distance from the treatment or monitoring site. Moreover, the increased surgical time, increased surgical trauma, and increased amount of implanted material associated with the use of leads and catheters can increase the risk to the patient of complications associated with the implantation of an IMD.
  • [0021]
    For example, IMDs that are used to treat or monitor the brain, e.g., to deliver deep brain stimulation (DBS) therapy, are implanted some distance away from the brain, e.g., within the subclavicular region of patients. The long leads that connect the implantable medical device to electrodes implanted within the brain require tunneling under the scalp and the skin of the neck, thereby requiring increased surgery and a prolonged amount of time under general anesthesia during the implant procedure, as well as increased recovery time. In some cases, tunneling the leads under the scalp and skin of the neck requires an additional surgical procedure under general anesthesia. The lengthy tract along the leads is more susceptible to infection, and the leads can erode the overlying scalp, forcing removal so that the scalp can heal. Further, the long leads running under the scalp and through the neck are more susceptible to fracture due to torsional and other forces caused by normal head and neck movements.
  • SUMMARY
  • [0022]
    In general, the invention is directed to an implantable medical device that includes a plurality of separately housed and flexibly interconnected modules. One of the modules is a control module that includes control electronics within a first housing. The control electronics control the functioning of the implantable medical device, and may include a processor.
  • [0023]
    A second module may be a power source module that includes a power source within a second housing. The power source provides power to the first module, e.g., to the control electronics. The power source may be a rechargeable power source, such as a rechargeable battery or a capacitor.
  • [0024]
    The first and second modules may be coupled by a flexible interconnect member, which may be hermetic. In various embodiments, the flexible interconnect member may include, for example, conductors to electrically couple the first and second modules. The flexible interconnect member may be flexible in more than one direction, providing the first and second modules with multiple degrees of freedom of motion with respect to each other including, in some embodiments, rotational motion. In exemplary embodiments, the flexible interconnect member provides at least three degrees of motion.
  • [0025]
    In some embodiments, the implantable medical device includes an overmold that at least partially encapsulates the first and second housings. In embodiments in which the overmold does not completely encapsulate the first and second housings, the overmold may encapsulate an upper portion of the housings. Where such an implantable medical device is implanted on the cranium, lower portions of the housings may contact the cranium. In some embodiments, the overmold is flexible, may be comprised of silicone, and may include at least two materials. Together, a flexible overmold and flexible interconnect member may allow the modular implantable medical device to be manipulated during implantation to substantially conform to cranium.
  • [0026]
    The implantable medical device may also include a third module, such as a recharge module that includes a coil within a third housing. In such embodiments, the coil inductively receives energy to recharge the power source within the second module. The overmold may at least partially encapsulate the third housing, or the third module may be tethered to the overmold by a tether member that allows the third module freedom of motion relative to the overmold such that the third module may be placed at a selected location some significant distance form the overmold and the other modules. The implantable medical device may include any number of modules in addition to the control module, and the additional modules are not limited to power source modules and/or recharge modules.
  • [0027]
    In exemplary embodiments, the implantable medical device is configured for implantation on the cranium of a patient. Further, the implantable medical device may comprise a neurostimulator, and the control module may include therapy delivery circuitry for delivery of stimulation to the brain of a patient. The implantable medical device may include a lead connection module formed within the overmold to receive a lead or lead extension.
  • [0028]
    In one embodiment, the invention is directed to an implantable medical device that includes a first module and a second module. The first module includes control electronics within a first housing. The second module includes a second housing. The implantable medical device further includes an overmold that at least partially encapsulates the first and second housings.
  • [0029]
    In another embodiment, the invention is directed to an implantable medical device that includes a first module and a second module. The first module includes control electronics within a first housing. The second module includes a power source that provides power to the first module housed within a second housing. The implantable medical device further includes an interconnect member that flexibly couples the first and second modules.
  • [0030]
    In another embodiment, the invention is directed to an implantable medical device that includes a first module and a second module. The first module includes control electronics housed within a first housing, and the second module that includes a power source that provides power to the first module housed within a second housing. The implantable medical device further includes a hermetic interconnect member that flexibly couples the first and second modules. The interconnect member is flexible in a plurality of directions and allows the first and second modules to have a plurality of degrees of freedom of movement relative to each other.
  • [0031]
    In another embodiment, the invention is directed to an implantable neurostimulator for delivering stimulation to a brain of a patient that includes a first module and second module. The first module includes control electronics and a therapy delivery circuit housed within a first housing. The control electronics control delivery of stimulation by the therapy delivery circuit. The second module includes a power source within a second housing that provides power to the control electronics and the therapy delivery circuit. The implantable neurostimulator further includes an interconnect member that flexibly couples the first and second modules and includes a conductor for delivery power from the power source to the control electronics and the therapy delivery circuit, and a flexible overmold that at least partially encapsulates the first and second housings.
  • [0032]
    In another embodiment, the invention is directed to an implantable medical device that includes control electronics and a rechargeable power source that provides power for the control electronics within a first housing. The implantable medical device further includes a recharge coil within a second housing that inductively receives energy to recharge the power source, and a flexible tether member that connects the first and second housings.
  • [0033]
    The invention may be capable of providing one or more advantages. For example, by distributing components of an implantable medical device amongst modules rather than including them within a single, rigid housing, the implantable medical device may be shaped and configured for implantation at locations within the human body for which implantation of conventional implantable medical devices is deemed undesirable. A flexible interconnect member and/or flexible overmold may allow multiples degrees of freedom of movement between modules of an implantable medical device, allowing the implantable medical device to conform to such areas, and in particular embodiments, to conform to surfaces within the human body such as the surface of the cranium. The flexible interconnect member and/or flexible overmold may allow the implantable medical device to be manipulated during implantation to conform to craniums with various sizes and shapes.
  • [0034]
    Because a modular implantable medical device according to the invention can be implanted on the cranium of a patient rather then more remotely from the brain, such as within a subclavicular region of the patient, the problems associated with the use of long leads needed to allow a remotely implanted medical device to access the brain may be diminished or avoided. Distribution of components of the implantable medical device within modules may reduce the effective thickness of the implantable medical device on the cranium making the implantable medical device less noticeable, e.g., more cosmetically appealing, when implanted on the cranium beneath the scalp of the patient. Further, in embodiments, that include an overmold, the overmold may be shaped to make the implantable medical device more cosmetically appealing and comfortable, and also more clinically acceptable, such as by including tapered edges that reduce the likelihood of skin erosion on the scalp over the device.
  • [0035]
    The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other embodiments of the invention will be apparent from the description and drawings, and from the claims.
  • BRIEF DESCRIPTION OF DRAWINGS
  • [0036]
    [0036]FIG. 1 is a conceptual diagram illustrating an example modular implantable medical device implanted on the cranium of a patient.
  • [0037]
    [0037]FIG. 2 is a top-view diagram further illustrating the modular implantable medical device of FIG. 1 implanted on the cranium of the patient.
  • [0038]
    [0038]FIG. 3 is a top-view diagram further illustrating the modular implantable medical device of FIG. 1.
  • [0039]
    [0039]FIG. 4 is top-view diagram illustrating a recharge module of the modular implantable medical device of FIG. 1.
  • [0040]
    [0040]FIG. 5 is a block diagram illustrating a control module of the modular implantable medical device of FIG. 1.
  • [0041]
    [0041]FIGS. 6A and 6B are top-view diagrams illustrating other example modular implantable medical devices.
  • [0042]
    [0042]FIG. 7 is a block diagram illustrating a power source module of the modular implantable medical device of FIG. 6B.
  • [0043]
    [0043]FIGS. 8A and 8B are cross-sectional diagrams illustrating two example configurations of the modular implantable medical device of FIG. 6B.
  • [0044]
    [0044]FIGS. 9A and 9B are top-view diagrams illustrating another example modular implantable medical device that include a tethered recharge module.
  • [0045]
    [0045]FIGS. 10, 11A, 11B and 12 are conceptual diagrams illustrating other example modular implantable medical devices.
  • [0046]
    [0046]FIG. 13 is a conceptual diagram illustrating a stacked circuit board.
  • [0047]
    [0047]FIGS. 14A and 14B are top-view diagrams illustrating other modular implantable medical devices.
  • DETAILED DESCRIPTION
  • [0048]
    [0048]FIG. 1 is a conceptual diagram illustrating an example modular implantable medical device (IMD) 10 implanted on the cranium 12 of a patient 14. As will be described in greater detail below, IMD 10 comprises a plurality of separately housed and flexibly interconnected modules. By distributing components of IMD 10 amongst modules rather than including them within a single, rigid housing, the implantable medical device may be shaped and configured for implantation at locations within patient 14 for which implantation of conventional IMDs is deemed undesirable. Further, the flexibility of the interconnection between modules of IMD 10 may allow multiples degrees of freedom of movement between the modules, which in turn may allow the implantable medical device to conform to such areas, and in particular embodiments, to conform to surfaces within patient 14 such as the surface of cranium 12.
  • [0049]
    In the illustrated example, modular IMD 10 is coupled to two leads 16A and 16B (collectively “leads 16”) that extend through holes within cranium 12, and into the brain of patient 14. In exemplary embodiments, each of leads 16 carries a plurality of electrodes, and IMD 10 delivers stimulation to the brain of patient 14 via the electrodes. Modular IMD 10 may be coupled to any number of leads 16, and in some embodiments is not coupled to any leads 16.
  • [0050]
    Because modular IMD 10 can be implanted on cranium 12 of patient 14 rather then more remotely from the brain of patient 14, such as within an subclavicular region of patient 14, the problems associated with the use of long leads needed to allow a remotely implanted IMDs to access the brain may be diminished or avoided. These problems include the requirement of tunneling under the scalp and the skin of the neck, increased surgery and recovery time, an additional procedure under general anesthesia, risk of infection or skin erosion along the track through which the leads are tunneled, and risk of lead fracture due to torsional and other forces caused by normal head and neck movements.
  • [0051]
    [0051]FIG. 2 is a top-view diagram further illustrating modular IMD 10 implanted on cranium 12 of the patient 14. In order to implant modular IMD 10 on cranium 12, an incision 20 is made through the scalp of patient 14, and a resulting flap of skin is pulled back to expose the desired area of cranium 12. The incision may, as shown in FIG. 2, be generally shaped like a “C.” Such an incision is commonly referred to as a “C-flap” incision.
  • [0052]
    Holes 22A and 22B (collectively “holes 22”) are drilled through cranium 12, and leads 16 are inserted through holes 22 and into the brain of patient 14. Caps may be placed over holes 22 as is known in the art. Leads 16 are connected to modular IMD 10, either directly or via a lead extension, and modular IMD 10 is placed at least partially within a pocket formed using a hand or a tool beneath the scalp behind holes 22.
  • [0053]
    Once positioned as desired on cranium 12 within the pocket, modular IMD 10 may then be fixed to cranium 12 using an attachment mechanism such as bone screws. The skin flap may be closed over modular IMD 10, and the incision may be stapled or sutured. The location on cranium 12 at which IMD 10 is illustrated as implanted in FIG. 2 is merely exemplary, and IMD 10 can be implanted anywhere on the surface of cranium 12. Further details regarding exemplary techniques for implanting IMD 10 on the cranium may be found in a commonly-assigned U.S. patent application entitled “IMPLANTATION OF LOW-PROFILE IMPLANTABLE MEDICAL DEVICE,” assigned Attorney Docket No.: 1023-330US01/P-11795.00.
  • [0054]
    Because of the flexibility provided by interconnect members and/or an overmold of modular IMD 10, the IMD may be manipulated during implantation such that it conforms to cranium 12. For example, in some embodiments a clinician can manipulate modular IMD 10 into conformance with cranium 12 while IMD 10 is on cranium 12 and fix modular IMD 10 into place using bone screws or the like. In other embodiments, the clinician may manipulate modular IMD 10 into conformance with cranium 12 with IMD 10 on and/or off of cranium 12, and IMD 10 may substantially retain the form into which it is manipulated.
  • [0055]
    As mentioned above, modular IMD 10 may deliver stimulation to the brain of patient 14 to, for example, provide deep brain stimulation (DBS) therapy, or to stimulate the cortex of the brain. Cortical stimulation may involve stimulation of the motor cortex. Modular IMD 10 may be used to treat any nervous system disorder including, but not limited to, epilepsy, pain, psychological disorders including mood and anxiety disorders, movement disorders (MVD), such as, but not limited to, essential tremor, Parkinson's disease, and neurodegenerative disorders.
  • [0056]
    However, modular IMD 10 is not limited to delivery of stimulation to the brain of patient, and may be employed with leads 16 deployed anywhere in the head or neck including, for example, leads deployed on or near the surface of the skull, leads deployed beneath the skull such as near or on the dura mater, leads placed adjacent cranial or other nerves in the neck or head, or leads placed directly on the surface of the brain. Moreover, modular IMD 10 is not limited to implantation on cranium 12. Indeed, modular IMD 10 may be implanted anywhere within patient 14. For example, modular IMD 10 can be implanted within the neck of patient 14, and deliver stimulation to the vagus nerve or the cervical region of the spinal cord.
  • [0057]
    Modular IMD 10 may alternatively be implanted within a pectoral region or the abdomen of patient 14 to act as a diaphragmatic pacer, or to provide any of the monitoring and therapy delivery functions known in the art to be associated with cardiac pacemakers. Further, modular IMD 10 may be implanted in the upper buttock region and deliver spinal cord, urological or gastrological stimulation therapy, or may be configured to be implanted within the periphery, e.g., limbs, of patient 14 for delivery of stimulation to the muscles and/or peripheral nervous system of patient 14. As is the case with cranium 12, the modularity of IMD 10 may enable implantation at some of these example locations for which implantation of conventional IMDs is generally deemed undesirable.
  • [0058]
    Modular IMD 10 is not limited to embodiments that deliver stimulation. For example, in some embodiments modular IMD 10 may additionally or alternatively monitor one or more physiological parameters and/or the activity of patient 14, and may include sensors for these purposes. Where a therapy is delivered, modular IMD 10 may operate in an open loop mode (also referred to as non-responsive operation), or in a closed loop mode (also referred to as responsive). Modular IMD 10 may also provide warnings based on the monitoring.
  • [0059]
    As discussed above, the ability of a modular IMD 10 according to the invention to be implanted close to a region within patient 14 to be monitored enables the use of shorter leads 16. Shorter leads 16 may advantageously improve the accuracy of such sensors by reducing noise attributable to leads 16. Shorter leads 16 may also advantageously reduce the negative affects of imaging techniques such as magnetic resonance imaging “MRI” on a person implanted with IMD 10.
  • [0060]
    Further, in some embodiments modular IMD 10 can additionally or alternatively deliver a therapeutic agent to patient 14, such as a pharmaceutical, biological, or genetic agent. Modular IMD 10 may be coupled to a catheter, and may include a pump to deliver the therapeutic agent via the catheter.
  • [0061]
    [0061]FIG. 3 is a top-view diagram further illustrating modular IMD 10. In the illustrated embodiment, modular IMD 10 includes three modules: a control module 30, a power source module 32, and a recharge module 34. As shown in FIG. 3, modules 30, 32 and 34 include separate housings 36, 38 and 40, respectively.
  • [0062]
    Control module 30 includes control electronics within the housing, e.g., electronics that control the monitoring and/or therapy delivery functions of modular IMD 10, such as a microprocessor. Control module 30 may also include circuits for telemetry communication with external programmers or other devices within the housing. Housing 36 of control module 30 may be hermetic in order to protect the control electronics therein, and in exemplary embodiments is formed of a rigid material, such as titanium, stainless steel, or a ceramic. In exemplary embodiments, housing 36 is a low-profile, concave housing, and techniques for arranging components of control module 30 to enable such a low-profile, concave housing are described in greater detail in a commonly-assigned U.S. patent application entitled “LOW-PROFILE IMPLANTABLE MEDICAL DEVICE,” assigned Attorney Docket No.: 1023-335US01/P-11801.00.
  • [0063]
    Power source module 32 includes a power source within housing 38. The power source provides power for components of other modules, such as the control electronics within control module 30. The power source may be any power source suitable for use within an IMD, such as one or more batteries, capacitors, solar cells, fuel cells, nuclear cells, or any combination thereof. In an exemplary embodiment, the power source comprises a rechargeable Lithium Ion battery, which may have a thin wound coil construction, or a foil pack or other non-coiled construction to more easily fit within housing 38 which may be less than 5 millimeters thick with an approximately one square inch surface area. Housing 38 may be hermetic, and may be formed of titanium, stainless steel, or a ceramic. Power source module 32 may include an insulator within housing 38 to isolate housing 38 from the power source.
  • [0064]
    Where the power source includes a rechargeable power, such as a rechargeable battery and/or a capacitor, modular IMD 10 may include recharge module 34. As shown in FIG. 4, recharge module 34 includes a recharge coil 42 within housing 40. Recharge coil 42 inductively receives energy from an external recharging unit (not illustrated) through the skin of patient 14 to recharge the power source. Recharge coil 42 may be formed of windings of copper or another highly conductive material. Housing 40 need not be hermetic, and may be formed of materials such as silicone, polymers and ceramics.
  • [0065]
    Housings 36, 38 and 40 may have any shape, including the round, coin shape and rectangular shapes with rounded edges illustrated in FIG. 3. Further, one or more surfaces of one or more of housings 36, 38 and 40 may be concave along at least one axis, and preferably two axes. Further details regarding the concavity of housings 36, 38 and 40 may be found in a commonly-assigned U.S. patent application entitled “CONCAVITY OF AN IMPLANTABLE MEDICAL DEVICE,” assigned Attorney Docket No.: 1023-336US01/P-11800.00.
  • [0066]
    Modules 30, 32 and 34 can be configured in a variety of ways, and the configuration illustrated in FIG. 3 is merely exemplary. Additional exemplary configurations are illustrated in FIGS. 6A, 6B, 9A, 9B, 10, 11A, 11B, 12, 14A and 14B, which are discussed below. Further, modular IMD 10 can include any number of modules, and may include other types of modules instead of or in addition to a power source module 32 and a recharge module 34. For example, modular IMD 10 can include additional power source modules, modules that include additional memory that is accessible by the control electronics within control module 30, modules that include reservoirs for storing therapeutic agents and pumps for delivering therapeutic agents to patient 14, and modules that include sensors sensing physiological parameters, such as pressures or blood flows, or the activity level of patient 12.
  • [0067]
    Power source module 32 is coupled to control module 30 by a flexible interconnect member 44, which encloses a conductor that allows transmission of energy from the power source of power source module 32 to components such as the control electronics within control module 30. In embodiments where energy is transferred via a DC voltage on the conductor, it may be necessary to make flexible interconnect member 44 hermetic. In embodiments in which flexible interconnect member 44 is hermetic, flexible interconnect member 44 may be made of titanium or stainless steel. In embodiments where energy is transferred via a charge-balance voltage on the conductor, such as an AC voltage, flexible interconnect member 44 need not be hermetic, and may be made of any material including silicone or various polymers.
  • [0068]
    In the illustrated embodiment, the control electronics of control module 30 regulates the recharging and discharging of the power source within power source module 32. Consequently, as shown in FIG. 3, recharge module 34 is coupled to control module 30 by a flexible interconnect member 46 that encloses a conductor that allows transmission of energy inductively received by coil 42 to control module 30. Because the energy is transferred on the conductor via a charge-balanced voltage, flexible interconnect member 46 need not be hermetic, and may be made of any material including titanium, stainless steel, ceramics, silicone or various polymers.
  • [0069]
    Interconnect members 44 and 46 are flexible. In some embodiments, as indicated above, interconnect members 44 and 46 are made of a flexible material such as silicone or a flexible polymer. In embodiments where flexible member 44 is hermetic and made of substantially less flexible material, such as titanium or stainless steel, the flexibility of interconnect member 44 is provided by the configuration and/or construction of flexible interconnect member 44.
  • [0070]
    Interconnect member 44 is flexible in a plurality of directions to provide modules 30 and 32 with multiple degrees of freedom of motion with respect to each other. In exemplary embodiments, interconnect member 44 provides at least three degrees of motion, and the degrees of motion provided include rotational motion. Further details regarding the configuration and/or construction of interconnect member 44 to provide such flexibility may be found in a commonly-assigned U.S. patent application entitled “COUPLING MODULE OF MODULAR IMPLANTABLE MEDICAL DEVICE,” assigned Attorney Docket No.: 1023-331US01/P-11796.00.
  • [0071]
    As shown in FIG. 3, modular IMD 10 includes an overmold 48, which may be flexible. In the illustrated embodiment, overmold 48 at least partially encapsulates each of housings 36, 38 and 40. Overmold 48 integrates modules 30, 32 and 34 into a desired form factor, but, where flexible, allows relative intermodule motion. In some embodiments, overmold 48 incorporates mechanical features to restrict intermodule motion to certain directions or within certain ranges. Overmold 48 may be made from silicone, and is some embodiments may be made from two or more materials of differing flexibility, such as silicone and a polyurethane. An exemplary polyurethane for this purpose is Tecothane®, which is commercially available from Hermedics Polymer Products, Wilmington, Mass. Use of the term “overmold” herein is not intend to limit the invention to embodiments in which overmold 48 is a molded structure. Overmold 48 may be a molded structure, or may be a structure formed by any process.
  • [0072]
    Overmold 48 can be shaped to contour to cranium 12, e.g., may be concave along at least one axis, and may be contoured at its edges to prevent skin erosion on the scalp of patient 14. The flexibility and shape of overmold 48 may improve the comfort and cosmetic appearance of modular IMD 10 under the scalp. Further details regarding the overmold, the concavity of the flexible overmold, and techniques for restricting intermodular motion in a modular IMD 10 may be found in a commonly-assigned U.S. patent application entitled “OVERMOLD FOR A MODULAR IMPLANTABLE MEDICAL DEVICE,” assigned Attorney Docket No.: 1023-332US01/P-11798.00, and a commonly-assigned U.S. patent application entitled “REDUCING RELATIVE INTERMODULE MOTION IN A MODULAR IMPLANTABLE MEDICAL DEVICE,” assigned Attorney Docket No.: 1023-333US01/P-11797.00.
  • [0073]
    In the illustrated embodiment, modular IMD 10 also includes lead connector modules 50A and 50B (collectively “lead connector modules 50”) formed within overmold 48 to receive leads 16 or lead extensions coupled to leads 16. Conductors 52 extend from lead connector modules 50 to hermetic feedthroughs (not illustrated) within housing 36 of control module 30. Lead connector modules 50 may be formed anywhere within overmold 48. In embodiments where overmold 48 includes a rigid material in addition to a flexible material, the rigid material may form at least part of lead connector modules 50 to secure leads 16 or lead extensions, and to protect conductors 52 from damage that may result from flexing within overmold 48.
  • [0074]
    [0074]FIG. 5 is a block diagram illustrating control module 30 of modular IMD 10. As described above, control module 30 includes control electronics that control the functioning of modular IMD 10 within housing 36. The control electronics include a processor 60, which may take the form of a microprocessor, digital signal processor (DSP), application specific integrated circuit (ASIC), field-programmable gate array (FPGA), or other logic circuitry.
  • [0075]
    Control module 30 also includes a memory 62, such as a read-only memory (ROM), random access memory (RAM), electronically-erasable programmable ROM (EEPROM), flash memory, or the like. Memory 62 may store program instructions that may be executed by processor 60 and thereby control the functioning of modular IMD 10. Processor 60 may also store data colleted during treatment and/or monitoring of patient 14 within memory 62.
  • [0076]
    In some embodiments, control module 30 includes telemetry circuitry 64, which enables processor 60 to communicate with other devices such as an external programming device via radio-frequency communication. Telemetry circuitry 64 may include a telemetry coil (not illustrated), which may be fabricated of windings of copper or another highly conductive material. The configuration and location of telemetry coil within housing 36 may be dictated by the available space within housing 36 and the communication requirements of telemetry circuitry 64. Further detail regarding the configuration and location of the telemetry coil may be found in a commonly-assigned U.S. patent application entitled “LOW-PROFILE IMPLANTABLE MEDICAL DEVICE,” assigned Attorney Docket No: 1023-335US01/P-11801.00.
  • [0077]
    In some embodiments modular IMD 10 delivers electrical stimulation, and more particularly, control module 30 includes therapy delivery circuitry 66 within housing 36 that generates electrical stimulation. In exemplary embodiments, therapy delivery circuitry 66 comprises circuits for the generation of electrical stimulation in the form of pulses, such as capacitors and switches. In embodiments in which modular IMD 10 is a neurostimulator coupled to leads 16 that include a plurality of electrodes, therapy delivery circuitry 66 may deliver the pulses to a switch matrix 68, which comprises an array of switches. In such embodiments, processor 60 interacts with switch matrix 68 to select electrodes for delivery of generated stimulation pulses. Based on the selections made by processor 60, switch matrix 68 delivers the pulses to conductors that pass through feedthroughs in housing 36 and to electrical contacts on leads 16 that are electrically coupled to the desired electrodes carried by leads 16.
  • [0078]
    The illustrated components of control module 30 receive energy from the power source within power source module 32 via interconnect member 44 (FIG. 3). In some embodiments in which the power source is rechargeable, control module 30 receives energy inductively captured by recharge module 34 via interconnect member 46, and includes power management circuitry 70 that controls the recharging and discharging of the power source. Power management circuitry 70 may ensure that the power source is not overcharged, over-discharged, or harmed. In some embodiments, power management circuitry 70 includes circuits to measure voltages, currents or temperatures associated with the power source, or rates of change of these parameters, and controls recharging and discharging according to the measured values. Power management circuitry 70 may also include circuits, such as rectifier circuits, for converting charge-balanced voltages, e.g., AC voltages, provided by recharge coil 42 (FIG. 4) into DC voltages for recharging the power source.
  • [0079]
    [0079]FIGS. 6A and 6B are top-view diagrams illustrating other example modular IMDs 80 and 90, respectively. More particularly, FIGS. 6A and 6B illustrate modular IMDs 80 and 90 that include alternative arrangements of modules 30, 32 and 34, flexible interconnect members 44 and 46, and lead connection modules 50. Further, FIGS. 6A and 6B illustrate alternatively shaped overmolds 82 and 92, respectively, that at least partially encapsulate modules 30, 32 and 34 of IMDs 80 and 90.
  • [0080]
    [0080]FIGS. 3 and 6A illustrate substantially triangular configurations of modules 30, 32 and 34 within modular IMDs 10 and 80, respectively. Further, overmolds 48 and 82 of IMDs 10 and 80 have substantially triangular shapes. Substantially triangular configurations of modules 30, 32 and 34 and substantially triangularly shaped overmolds such as overmolds 48 and 82 may be preferred for some implantations, such as that described with reference to FIG. 2, in order to reduce the depth of the pocket formed under the scalp of patient 14. Reduced pocket depth may allow for easier explant of modular IMDs 10 and 80 in the event explant is required. However, other configurations are possible, such as the substantially linear configuration of modules 30, 32 and 34 within modular IMD 90 illustrated FIG. 6B.
  • [0081]
    Although illustrated in FIGS. 3, 6A and 6B as connecting recharge module 34 to control module 30, in some embodiments flexible interconnect member 44 directly connects recharge module 34 to power source module 32. Consequently, in such embodiments power source module 32 includes circuitry to control the recharging and discharging of the power source instead of, or in addition to power management circuit 70 within control module 30.
  • [0082]
    [0082]FIG. 7 is a block diagram illustrating power source module 32 of modular IMD 90. Power source module 32 includes a rechargeable power source 100 within housing 38, which may include a battery and/or a capacitor. In the illustrated embodiment in which power source module 32 directly receives energy inductively captured by recharge module 34 via flexible interconnect member 44, power source module 32 also include power management circuit 102 that controls the recharging and discharging of power source 100. As described above with reference to power management circuitry 70 illustrated in FIG. 5, power management circuitry 102 may ensure that power source 100 is not overcharged, over-discharged, or harmed. In some embodiments, power management circuitry 102 includes circuits to measure voltages, currents or temperatures associated with power source 100, or rates of change of these parameters, and controls recharging and discharging of power source 100 according to the measured values.
  • [0083]
    Power management circuitry 102 may also include circuits, such as rectifier circuits, for converting charge-balanced voltages, e.g., AC voltages, provided by recharge coil 42 (FIG. 4) into DC voltages for recharging power source 100. In some embodiments in which interconnect member 44 is non-hermetic, power management circuit 102 includes modulating circuits, i.e., circuits that enable power management circuit 102 to deliver energy to control module 30 in the form of charge-balanced voltages on a conductor. In such embodiments, control module 30 includes circuits, such as rectifier circuits, to convert the charge-balanced voltages to DC voltages for use by components of control module 30.
  • [0084]
    [0084]FIGS. 8A and 8B are cross-sectional diagrams illustrating two example configurations of overmold 92 of modular IMD 90, the cross-section taken along axis 94 (FIG. 6B). FIG. 8A illustrates an embodiment of IMD 90 in which overmold 92 fully encapsulates modules 30, 32 and 34, while FIG. 8B illustrates an embodiment of IMD 90 in which overmold 92 partially encapsulates modules 30, 32 and 34. In embodiments where overmold 92 partially encapsulates modules 30, 32 and 34, overmold 92 leaves portions 110, 112 and 114 of modules 30, 32 and 34 exposed, respectively. Portions 110, 112 and 114 may, as illustrated in FIG. 8B, be lower portions of modules 30, 32 and 34, e.g., portions of the modules that are proximate to cranium 12 when modular IMD 90 is implanted thereon.
  • [0085]
    Embodiments in which overmold 92 fully encapsulates modules 30, 32 and 34 may be preferred as providing greater patient comfort and protection of the modules. However, in some embodiments in which portions 110, 112 and 114 are exposed, troughs may be drilled into the surface of cranium 12 that are sized to receive the portions. By recessing portions 110, 112 and 114 into such troughs, the height of modular IMD 90 above cranium 12 may be reduced.
  • [0086]
    [0086]FIGS. 9A and 9B are top-view diagrams illustrating another example modular IMD 120. In the illustrated embodiment, recharge module 34 is not encapsulated by overmold 122, but is instead tethered to overmold 122 by a flexible tether member 124. Flexible tether member 124 is made of a flexible material, such as silicone, to allow substantial movement of recharge module 34 relative to other modules 30 and 32 as illustrated in FIG. 9B. In some embodiments, flexible tether member 124 is shaped as a helix to allow recharge module freedom of movement some significant distance away from other modules 30 and 32. Recharge module 34 can be moved to improve inductive coupling for energy transfer and/or the cosmetics of modular IMD 120 when implanted on cranium 12.
  • [0087]
    [0087]FIGS. 10, 11A, 11B and 12 are conceptual diagrams illustrating other example modular IMDs 130, 140 and 150. Modular IMD 130 of FIG. 10 does not include recharge module 34. Rather, recharge coil 42 is embedded within overmold 132, and surrounds control module 30 and power source module 32.
  • [0088]
    In some embodiments, such as modular IMD 140 illustrated in FIGS. 11A and 11B, control module 30 and power source module 32 are not separately housed. Rather, as illustrated in FIG. 11A, modular IMD 140 includes a single housing 142 to house both control module 30 and power source module 32. Housing 142 may be hermetic and formed of titanium, stainless steel, or a ceramic. Recharge module 34 may, as shown in FIG. 11A, be tethered to housing 142 by flexible tether member 124 so that recharge module 34 can be moved freely relative to housing 142. Further, modular IMD 140 may, as shown in FIG. 11A, include a ceramic connector block 144 to receive leads 16.
  • [0089]
    [0089]FIG. 11B illustrates a side-profile of modular IMD 140. Housing 142 may be a low-profile housing with a thickness 146 that is approximately less than or equal to 6 millimeters. Techniques for arranging components of an IMD to enable a low-profile housing may be found in the commonly-assigned U.S. patent application entitled “LOW-PROFILE IMPLANTABLE MEDICAL DEVICE,” assigned Attorney Docket No: 1023-335US01/P-11801.00. A low-profile housing 142 may allow modular IMD 140 to be implanted, for example, within an upper buttocks region of patient 14.
  • [0090]
    [0090]FIG. 12 is a conceptual diagram illustrating a modular IMD 150 in which housing 36 of control module 30 and housing 38 of power source module 32 have substantially cylindrical shapes. The substantially cylindrical shapes of control module 30 and power source module 32 may enable IMD 150 to be implanted within the periphery, e.g., the limbs, of patient 14.
  • [0091]
    As illustrated in FIG. 13, a circuit board 160 within control module 30 may include flex tape regions 162 that enable the circuit board 160 to have a “stacked” configuration. The stacked configuration of circuit board 160 can enable circuit board 160 to fit within cylindrical housing 36 illustrated in FIG. 12. In some embodiments, circuit board 160 may be constructed entirely of flex tape, and may be have a “rolled” configuration that can enable circuit board 160 to fit within cylindrical housing 36 illustrated in FIG. 12. A variety of primary and rechargeable batteries that have substantially cylindrical shapes are commercially available, and can be used as a cylindrically-shaped power source module 32.
  • [0092]
    [0092]FIGS. 14A and 14B are top-view diagrams illustrating other example modular IMDs 170 and 180. Modular IMDs 170 and 180 include at least one module in addition to control module 30, power source module 32, and recharge module 34. In particular, instead of or in addition to delivering electrical stimulation, modular IMDs 170 and 180 deliver one or more therapeutic agents to patient 14.
  • [0093]
    Modular IMDs 170 and 180 may be coupled to one or more catheters for delivery of the therapeutic agent to patient 14. Modular IMD 170 includes a reservoir module 172 that contains the therapeutic agent within a housing. The housing may contain a bladder that holds the therapeutic agent, and may provide access to the bladder for refilling. The housing may be formed of, for example, titanium, stainless steel, a ceramic, a polymer, or silicone.
  • [0094]
    In such embodiments, control module 30 includes a pump (not shown), and processor 60 (FIG. 5) controls delivery of the therapeutic agent by the pump. The pump within control module 30 receives the therapeutic agent from reservoir module 172 via a flexible interconnect member 174 that includes to enable transfer of the therapeutic agent. Flexible interconnect member 174 need not be hermetic, and may be made from, for example, titanium, stainless steel, a ceramic, a polymer, or silicone. An overmold 176 may at least partially encapsulate the housing of reservoir module 172 in addition to the housings of control module 30, power source module 32, and recharge module 34.
  • [0095]
    Modular IMD 180 illustrated in FIG. 14B includes a separately housed pump module 182 that includes a pump. The pump within pump module 182 may be used to deliver the therapeutic agent within reservoir module 172 instead of or in addition to a pump within control module 30. In the illustrated embodiment, pump module 182 rather than control module 30 is coupled to reservoir module 172 by flexible interconnect member 174, and the pump within pump module 182 receives the therapeutic agent within reservoir module 172 via a lumen within flexible interconnect member 174.
  • [0096]
    The housing of pump module 182 may be made from, for example, titanium, stainless steel, or a ceramic. A flexible interconnect member 184 carries one or more conductors used by processor 60 (FIG. 5) to control the delivery of the therapeutic agent to patient 14 by the pump within pump module 182. The flexible interconnect member 184 may need to be hermetic, and may be made from, for example, titanium, stainless steel, or a ceramic. A flexible overmold 186 may at least partially encapsulate the housings of reservoir module 172 and pump module 182, in addition to the housings of control module 30, power source module 32, and recharge module 34.
  • [0097]
    Various embodiments of the invention have been described. These and other embodiments are within the scope of the following claims.
Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
US3720874 *8 Nov 197113 Mar 1973Motorola IncDipole antenna arrangement for radio with separate speaker-microphone assembly
US3724467 *23 Abr 19713 Abr 1973Avery Labor IncElectrode implant for the neuro-stimulation of the spinal cord
US3888260 *26 Abr 197410 Jun 1975Univ Johns HopkinsRechargeable demand inhibited cardiac pacer and tissue stimulator
US4010760 *23 May 19758 Mar 1977Medtronic, Inc.Coupling assembly for implantable electromedical devices
US4013081 *19 Abr 197622 Mar 1977Arco Medical Products CompanyPediatric cardiac pacer system
US4040412 *3 Feb 19769 Ago 1977Sato Takuya RBioelectrodes
US4256115 *14 Ene 198017 Mar 1981American Technology, Inc.Leadless cardiac pacer
US4266552 *13 Nov 197912 May 1981Medtronic, Inc.Lead anchoring bobbin
US4328813 *20 Oct 198011 May 1982Medtronic, Inc.Brain lead anchoring system
US4399819 *21 Dic 198123 Ago 1983Telectronics Pty. Ltd.Heart pacer mechanical construction
US4399820 *5 Feb 198223 Ago 1983Alexander WirtzfeldProcess and device for regulating the stimulation frequency of heart pacemakers
US4499907 *15 Nov 198219 Feb 1985Medtronic, Inc.Energy limiting cardioversion lead
US4911178 *2 Jun 198827 Mar 1990Neal Carol APacemaker wire dressing
US4928696 *26 Jul 198929 May 1990Mindcenter CorporationElectrode-supporting headset
US4934368 *21 Ene 198819 Jun 1990Myo/Kinetics Systems, Inc.Multi-electrode neurological stimulation apparatus
US5085644 *20 May 19914 Feb 1992Pudenz-Schulte Medical Research CorporationSterilizable medication infusion device with dose recharge restriction
US5197332 *19 Feb 199230 Mar 1993Calmed Technology, Inc.Headset hearing tester and hearing aid programmer
US5220929 *2 Oct 199122 Jun 1993Ventritex, Inc.Bio-compatible boot for implantable medical device
US5312440 *24 Mar 199217 May 1994Siemens AktiengesellschaftImplantable defibrillator arrangement
US5314451 *15 Ene 199324 May 1994Medtronic, Inc.Replaceable battery for implantable medical device
US5314453 *6 Dic 199124 May 1994Spinal Cord SocietyPosition sensitive power transfer antenna
US5411537 *29 Oct 19932 May 1995Intermedics, Inc.Rechargeable biomedical battery powered devices with recharging and control system therefor
US5411538 *1 Nov 19932 May 1995Intermedics, Inc.Implantable medical device with detachable battery or electronic circuit
US5480416 *22 Sep 19942 Ene 1996Intermedics, Inc.Cardiac pacemaker with universal coating
US5489225 *16 Dic 19936 Feb 1996Ventritex, Inc.Electrical terminal with a collet grip for a defibrillator
US5613935 *16 Dic 199425 Mar 1997Jarvik; RobertHigh reliability cardiac assist system
US5638832 *7 Jun 199517 Jun 1997Interval Research CorporationProgrammable subcutaneous visible implant
US5645586 *8 Jul 19948 Jul 1997Ventritex, Inc.Conforming implantable defibrillator
US5741313 *9 Sep 199621 Abr 1998Pacesetter, Inc.Implantable medical device with a reduced volumetric configuration and improved shock stabilization
US5755743 *16 Oct 199626 May 1998Implex Gmbh SpezialhorgerateImplantable unit
US5769874 *24 Mar 199723 Jun 1998Pacesetter AbActive medical implant with a hermetically sealed capsule
US5776169 *28 Abr 19977 Jul 1998Sulzer Intermedics Inc.Implantable cardiac stimulator for minimally invasive implantation
US5873899 *16 Ene 199623 Feb 1999Pacesetter Inc.Implantable medical device having compliant support for internal components
US5876424 *23 Ene 19972 Mar 1999Cardiac Pacemakers, Inc.Ultra-thin hermetic enclosure for implantable medical devices
US5895414 *10 Abr 199720 Abr 1999Sanchez-Zambrano; SergioPacemaker housing
US5896647 *2 Jun 199727 Abr 1999Nec Moli Energy (Canada) LimitedSealed electrical device with unitary fill port and terminal construction
US5919215 *27 Ago 19986 Jul 1999Medtronic, Inc.Attachment apparatus for an implantable medical device employing ultrasonic energy
US6016449 *27 Oct 199718 Ene 2000Neuropace, Inc.System for treatment of neurological disorders
US6016593 *10 Abr 199825 Ene 2000Kyrstein Investments Ltd.Electric drive system for planer mill infeed and outfeed rolls
US6061593 *24 Abr 19989 May 2000Neuropace, Inc.EEG d-c voltage shift as a means for detecting the onset of a neurological event
US6067474 *31 Jul 199823 May 2000Advanced Bionics CorporationImplantable device with improved battery recharging and powering configuration
US6176879 *11 Dic 199823 Ene 2001Implex Aktienegesellschaft Hearing TechnologyMedical implant
US6218016 *27 Sep 199917 Abr 2001Medtronic Ave, Inc.Lubricious, drug-accommodating coating
US6230049 *13 Ago 19998 May 2001Neuro Pace, Inc.Integrated system for EEG monitoring and electrical stimulation with a multiplicity of electrodes
US6241032 *7 Sep 19995 Jun 2001Thomas E. Falgout, Sr.One-way drill string clutch
US6248080 *26 Abr 199919 Jun 2001Medtronic, Inc.Intracranial monitoring and therapy delivery control device, system and method
US6259951 *12 May 200010 Jul 2001Advanced Bionics CorporationImplantable cochlear stimulator system incorporating combination electrode/transducer
US6263225 *30 Nov 199817 Jul 2001University Of Iowa Research FoundationStereotactic electrode assembly
US6266556 *27 Abr 199824 Jul 2001Beth Israel Deaconess Medical Center, Inc.Method and apparatus for recording an electroencephalogram during transcranial magnetic stimulation
US6269266 *23 Jul 199931 Jul 2001Implex Aktiengesellschaft Hearing TechnologyPower supply module for an implantable device
US6354299 *30 Jun 200012 Mar 2002Neuropace, Inc.Implantable device for patient communication
US6356792 *20 Ene 200012 Mar 2002Electro Core Technologies, LlcSkull mounted electrode lead securing assembly
US6358281 *29 Nov 199919 Mar 2002Epic Biosonics Inc.Totally implantable cochlear prosthesis
US6360122 *2 Ago 200019 Mar 2002Neuropace, Inc.Data recording methods for an implantable device
US6366813 *25 Jun 19992 Abr 2002Dilorenzo Daniel J.Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease
US6405079 *22 Sep 200011 Jun 2002Mehdi M. AnsariniaStimulation method for the dural venous sinuses and adjacent dura for treatment of medical conditions
US6415184 *6 Ene 20002 Jul 2002Ball Semiconductor, Inc.Implantable neuro-stimulator with ball implant
US6427086 *21 Abr 200030 Jul 2002Neuropace, Inc.Means and method for the intracranial placement of a neurostimulator
US6505077 *19 Jun 20007 Ene 2003Medtronic, Inc.Implantable medical device with external recharging coil electrical connection
US6516227 *26 Jul 20004 Feb 2003Advanced Bionics CorporationRechargeable spinal cord stimulator system
US6516808 *14 Jun 200111 Feb 2003Alfred E. Mann Foundation For Scientific ResearchHermetic feedthrough for an implantable device
US6517476 *30 May 200011 Feb 2003Otologics LlcConnector for implantable hearing aid
US6537200 *28 Mar 200125 Mar 2003Cochlear LimitedPartially or fully implantable hearing system
US6554762 *27 Ago 200129 Abr 2003Cochlear LimitedImplantable hearing system with means for measuring its coupling quality
US6560486 *12 Oct 19996 May 2003Ivan OsorioBi-directional cerebral interface system
US6565503 *13 Abr 200120 May 2003Cochlear LimitedAt least partially implantable system for rehabilitation of hearing disorder
US6567703 *8 Nov 200020 May 2003Medtronic, Inc.Implantable medical device incorporating miniaturized circuit module
US6575894 *13 Abr 200110 Jun 2003Cochlear LimitedAt least partially implantable system for rehabilitation of a hearing disorder
US6597954 *28 Nov 200022 Jul 2003Neuropace, Inc.System and method for controlling epileptic seizures with spatially separated detection and stimulation electrodes
US6726678 *22 Feb 200127 Abr 2004Isurgical, LlcImplantable reservoir and system for delivery of a therapeutic agent
US6882881 *19 Oct 200019 Abr 2005The Johns Hopkins UniversityTechniques using heat flow management, stimulation, and signal analysis to treat medical disorders
US7010351 *8 Mar 20017 Mar 2006Northstar Neuroscience, Inc.Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US7212864 *9 Dic 20031 May 2007Medtronic, Inc.Modular implantable medical device
US7242982 *9 Dic 200310 Jul 2007Medtronic, Inc.Overmold for a modular implantable medical device
US20020002390 *17 Ago 20013 Ene 2002Fischell Robert E.Implantable neurostimulator having a data communication link
US20020013510 *26 Jun 200131 Ene 2002Olympus Optical Co., Ltd.Endoscope device
US20020019669 *15 Oct 200114 Feb 2002Epic Biosonics Inc.Totally implantable cochlear prosthesis
US20020051550 *27 Ago 20012 May 2002Hans LeysiefferImplantable hermetically sealed housing for an implantable medical device and process for producing the same
US20020068958 *27 Ago 20016 Jun 2002Cameron Health, Inc.Radian curve shaped implantable cardioverter-defibrillator canister
US20020087201 *8 Mar 20014 Jul 2002Firlik Andrew D.Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US20020099412 *12 Mar 200225 Jul 2002Neuropace, Inc.Methods for using an implantable device for patient communication
US20030004428 *28 Jun 20012 Ene 2003Pless Benjamin D.Seizure sensing and detection using an implantable device
US20030004546 *8 Jul 20022 Ene 2003Casey Don E.Subcutaneously implantable power supply
US20030040781 *22 Oct 200227 Feb 2003Medtronic, Inc.Implantable medical device employing integral housing for a formable flat battery
US20030073972 *12 Nov 200217 Abr 2003Biocardia, Inc.Implant delivery catheter system and methods for its use
US20030085684 *5 Dic 20028 May 2003Quallion LlcImplantable medical power module
US20030088294 *2 Nov 20018 May 2003Lockheed Martin CorporationMovement timing stimulator
US20030109903 *12 Dic 200112 Jun 2003Epic Biosonics Inc.Low profile subcutaneous enclosure
US20030120320 *20 Dic 200126 Jun 2003Medtronic,Inc.Implantable medical device having a housing or component case with an insulating material formed thereon, and methods of making same
US20030130706 *27 Sep 200210 Jul 2003Sheffield W. DouglasMethods and apparatus for effectuating a lasting change in a neural-function of a patient
US20040082977 *25 Oct 200229 Abr 2004Engmark David B.Implantable medical device with air core antenna assembly
US20040102828 *18 Abr 200327 May 2004Lowry David WarrenMethods and systems employing intracranial electrodes for neurostimulation and/or electroencephalography
US20050033378 *9 Dic 200310 Feb 2005Sheffield Warren DouglasMethods for treating and/or collecting information regarding neurological disorders, including language disorders
US20050070971 *2 Ago 200431 Mar 2005Brad FowlerApparatus and methods for applying neural stimulation to a patient
US20050075679 *7 May 20047 Abr 2005Gliner Bradford E.Methods and apparatuses for treating neurological disorders by electrically stimulating cells implanted in the nervous system
US20060116743 *8 Ago 20031 Jun 2006Peter GibsonFixation system for an implantable medical device
US20060129205 *3 Feb 200615 Jun 2006Boveja Birinder RMethod and system for cortical stimulation with rectangular and/or complex electrical pulses to provide therapy for stroke and other neurological disorders
USH1465 *8 Sep 19934 Jul 1995Medtronic, Inc.Implantable lead infection barrier
USRE36120 *7 Feb 19962 Mar 1999Karell; Manuel L.Snopper--the snoring stopper anti-snoring mouth device
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
US728808514 Sep 200130 Oct 2007Medtronic, Inc.Permanent magnet solenoid pump for an implantable therapeutic substance delivery device
US7337010 *29 Oct 200426 Feb 2008Medtronic, Inc.Medical device having lithium-ion battery
US7529586 *9 Dic 20035 May 2009Medtronic, Inc.Concavity of an implantable medical device
US766250929 Oct 200416 Feb 2010Medtronic, Inc.Lithium-ion battery
US767352810 May 20069 Mar 2010Euisik YoonFlexible modular sensor systems
US768274529 Oct 200423 Mar 2010Medtronic, Inc.Medical device having lithium-ion battery
US774098523 Abr 200922 Jun 2010Medtronic, Inc.Lithium-ion battery
US775856827 May 200420 Jul 2010Medtronic, Inc.Implantable therapeutic substance delivery device
US779486929 Jul 200914 Sep 2010Medtronic, Inc.Lithium-ion battery
US780348125 Sep 200928 Sep 2010Medtronic, Inc,Lithium-ion battery
US780729929 Oct 20045 Oct 2010Medtronic, Inc.Lithium-ion battery
US781170529 Oct 200412 Oct 2010Medtronic, Inc.Lithium-ion battery
US7815667 *20 Jul 200619 Oct 2010Pyles Stephen TPower source for an implantable medical device
US785823628 Jul 200928 Dic 2010Medtronic, Inc.Lithium-ion battery
US787538921 May 200925 Ene 2011Medtronic, Inc.Lithium-ion battery
US787949529 Oct 20041 Feb 2011Medtronic, Inc.Medical device having lithium-ion battery
US788179631 Jul 20071 Feb 2011Medtronic, Inc.Implantable medical device with a nonhermetic battery
US788379022 Sep 20098 Feb 2011Medtronic, Inc.Method of preventing over-discharge of battery
US792774229 Sep 200819 Abr 2011Medtronic, Inc.Negative-limited lithium-ion battery
US793198727 May 201026 Abr 2011Medtronic, Inc.Lithium-ion battery
US80863135 Ago 200927 Dic 2011Medtronic, Inc.Implantable medical device with anti-infection agent
US810571413 Jul 200731 Ene 2012Medtronic, Inc.Lithium-ion battery
US81782426 Abr 201115 May 2012Medtronic, Inc.Lithium-ion battery
US828047810 Ago 20092 Oct 2012Medtronic, Inc.Evaluation of implantation site for implantation of implantable medical device
US838326913 Abr 201126 Feb 2013Medtronic, Inc.Negative-limited lithium-ion battery
US839199018 May 20055 Mar 2013Cardiac Pacemakers, Inc.Modular antitachyarrhythmia therapy system
US859480630 Abr 201026 Nov 2013Cyberonics, Inc.Recharging and communication lead for an implantable device
US864985929 Oct 201211 Feb 2014Cardiac Pacemakers, Inc.Modular antitachyarrhythmia therapy system
US86664979 Nov 20104 Mar 2014Medtronic, Inc.Coupling module of a modular implantable medical device
US878504626 Ago 201022 Jul 2014Medtronic, Inc.Lithium-ion battery
US8862235 *9 Nov 200714 Oct 2014Alfred E. Mann Foundation For Scientific ResearchBrain implant device
US890350027 Ene 20142 Dic 2014Cardiac Pacemakers, Inc.Modular antitachyarrhythmia therapy system
US898045330 Abr 200817 Mar 2015Medtronic, Inc.Formation process for lithium-ion batteries
US90024679 Oct 20147 Abr 2015Cardiac Pacemakers, Inc.Modular antitachyarrhythmia therapy system
US906514513 Jul 200723 Jun 2015Medtronic, Inc.Lithium-ion battery
US90770226 Dic 20107 Jul 2015Medtronic, Inc.Lithium-ion battery
US908490128 Abr 200621 Jul 2015Medtronic, Inc.Cranial implant
US921629722 Mar 201122 Dic 2015Medtronic, Inc.Flexible recharge coil techniques
US92421135 Mar 201526 Ene 2016Cardiac Pacemarkers, Inc.Modular antitachyarrhythmia therapy system
US928758027 Jul 201115 Mar 2016Medtronic, Inc.Battery with auxiliary electrode
US934392323 Ago 201217 May 2016Cyberonics, Inc.Implantable medical device with backscatter signal based communication
US93521641 Jun 201531 May 2016Cardiac Pacemakers, Inc.Modular antitachyarrhythmia therapy system
US939343230 Oct 200919 Jul 2016Medtronic, Inc.Non-hermetic direct current interconnect
US950440225 Mar 201529 Nov 2016Medtronic, Inc.Cranial implant
US952690926 Ago 201527 Dic 2016Cardiac Pacemakers, Inc.Medical device with triggered blanking period
US958732131 Mar 20157 Mar 2017Medtronic Inc.Auxiliary electrode for lithium-ion battery
US95923918 Ene 201514 Mar 2017Cardiac Pacemakers, Inc.Systems and methods for detecting cardiac arrhythmias
US9622677 *3 Sep 201418 Abr 2017Alfred E. Mann Foundation For Scientific ResearchBrain implant device
US96692301 Feb 20166 Jun 2017Cardiac Pacemakers, Inc.Systems and methods for treating cardiac arrhythmias
US20020173773 *14 Sep 200121 Nov 2002Olsen James M.Permanent magnet solenoid pump for an implantable therapeutic substance delivery device
US20040220553 *27 May 20044 Nov 2004Medtronic, Inc.Implantable therapeutic substance delivery device
US20060093871 *29 Oct 20044 May 2006Medtronic, Inc.Lithium-ion battery
US20060093894 *27 Oct 20054 May 2006Medtronic, Inc.Method for charging lithium-ion battery
US20060093916 *29 Oct 20044 May 2006Medtronic, Inc.Lithium-ion battery
US20060095094 *29 Oct 20044 May 2006Medtronic, Inc.Medical device having lithium-ion battery
US20060254369 *10 May 200616 Nov 2006Euisik YoonFlexible modular sensor systems
US20060265018 *18 May 200523 Nov 2006Cardiac Pacemakers, Inc.Modular antitachyarrhythmia therapy system
US20070055307 *20 Jul 20068 Mar 2007Pyles Stephen TPower source for an implantable medical device
US20080044728 *13 Jul 200721 Feb 2008Medtronic, Inc.Lithium-ion battery
US20140343621 *7 Ago 201420 Nov 2014Sapiens Steering Brain Stimulation B.V.Probe system for brain applications
US20160151621 *30 Nov 20152 Jun 2016Cardiac Pacemaker, Inc.Implantable medical device with stacked circuit components
USRE44340 *8 May 20122 Jul 2013Stephen T. PylesPower source for an implantable medical device
WO2009042295A1 *11 Ago 20082 Abr 2009Cardiac Pacemakers, Inc.Hinged anchors for wireless pacing electrodes
WO2016038599A1 *6 Sep 201517 Mar 2016Newpace Ltd.Flexible rechargeable implantable subcutaneous medical device structure and method of assembly
Clasificaciones
Clasificación de EE.UU.607/45
Clasificación internacionalA61N1/375, A61N1/36
Clasificación cooperativaA61N1/3605, A61N1/3758, A61N1/375, A61N1/3754
Clasificación europeaA61N1/36, A61N1/375, A61N1/375A2
Eventos legales
FechaCódigoEventoDescripción
24 May 2004ASAssignment
Owner name: MEDTRONIC, INC., MINNESOTA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WAHLSTRAND, CARL D.;SINGHAL, RUCHIKA;SKIME, ROBERT M.;REEL/FRAME:015362/0657;SIGNING DATES FROM 20040510 TO 20040512